Author:
Usmani Sharjeel,Ahmed Najeeb,Marafi Fahad,Rasheed Rashid,Amanguno Henney G.,al kandari Fareeda
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference10 articles.
1. Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients;Manzara;Anticancer Res,2006
2. Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy;Nilsson;Cancer Res,1995
3. Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours;Kabasakal;Eur J Nucl Med Mol Imaging,2012
4. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5;Wild;Eur J Nucl Med Mol Imaging,2005
5. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE;Virgolini;Eur J Nucl Med Mol Imaging,2010
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献